Keyphrases
European Consensus
100%
Cutaneous Squamous Cell Carcinoma (cSCC)
100%
Consensus-based
100%
Surgical Margin
37%
Advanced Cutaneous Squamous Cell Carcinoma
37%
High Risk
25%
Radiotherapy
25%
Primary Cutaneous
25%
Locally Advanced Cutaneous Squamous Cell Carcinoma
25%
Metastatic Cutaneous Squamous Cell Carcinoma
25%
Supportive Care
12%
Tumor
12%
Quality of Life
12%
Expert Consensus
12%
Systemic Treatment
12%
Chemotherapy
12%
Comorbidity
12%
Expert Panel
12%
European Associations
12%
Symptom Management
12%
Academy
12%
European Society
12%
Low Risk
12%
European Medicines Agency
12%
Cancer Treatment
12%
Adjuvant Radiotherapy
12%
Palliative Radiotherapy
12%
Distant Metastasis
12%
European Organizations
12%
Surgical Excision
12%
Lymph Node Dissection
12%
Immunosuppression
12%
Frailty
12%
Significant Benefit
12%
Multidisciplinary Panel
12%
Nodal Metastasis
12%
Cetuximab
12%
European Union of Medical Specialists
12%
Risk Characteristics
12%
Treatment Recommendations
12%
Curative Surgery
12%
Patient Morbidity
12%
Underlying Risk
12%
Epidermal Growth Factor Receptor Inhibitors
12%
Systemic Agents
12%
Best Supportive Care
12%
High-risk Factors
12%
Surgical Candidate
12%
Review Guidelines
12%
Anti-PD-1
12%
First-line Systemic Treatment
12%
Dermato-oncology
12%
Evidence-based Literature
12%
Treatment Considerations
12%
Controlled Surgery
12%
Venereology
12%
Informed Decision-making
12%
Board Decisions
12%
Cemiplimab
12%
Multidisciplinary Board
12%
INIS
guidelines
100%
carcinomas
100%
patients
50%
surgery
50%
risks
42%
radiotherapy
28%
metastases
28%
recommendations
21%
margins
21%
management
14%
cancer
7%
tumors
7%
symptoms
7%
receptors
7%
education
7%
assessments
7%
morbidity
7%
reviews
7%
quality of life
7%
toxicity
7%
chemotherapy
7%
lymph nodes
7%
decision making
7%
panels
7%
investigations
7%
european union
7%
medicines
7%
food and drug administration
7%
growth factors
7%
immunosuppression
7%
Medicine and Dentistry
Skin Carcinoma
100%
Radiation Therapy
21%
Surgical Margin
14%
Systemic Therapy
14%
Supportive Care
14%
Dermatology
14%
Oncology
7%
Retroperitoneal Lymph Node Dissection
7%
Neoplasm
7%
Quality of Life
7%
Medicine
7%
Immunosuppressive Treatment
7%
Cancer Treatment
7%
Cetuximab
7%
Shared Decision Making
7%
Epidermal Growth Factor Receptor Kinase Inhibitor
7%
Frailty
7%
Nodal Metastasis
7%
Adjuvant Radiotherapy
7%
Symptom Management
7%
Cemiplimab
7%
Venereology
7%
Comorbidity
7%